iDNA Genomics Public (CYS:IDNA) Accounts Payable & Accrued Expense : €0.00 Mil (As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is iDNA Genomics Public Accounts Payable & Accrued Expense?

iDNA Genomics Public Accounts Payable & Accrued Expense Historical Data

The historical data trend for iDNA Genomics Public's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iDNA Genomics Public Accounts Payable & Accrued Expense Chart

iDNA Genomics Public Annual Data

Trend

Accounts Payable & Accrued Expense

iDNA Genomics Public Semi-Annual Data

Accounts Payable & Accrued Expense

iDNA Genomics Public Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

iDNA Genomics Public Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » iDNA Genomics Public Ltd (CYS:IDNA) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Evrota 25- 27, Kifissia, GRC, 145 64

Website

https://www.idnagenomics.com

iDNA Genomics Public Ltd is engaged in performing precision medicine and genetic analysis (DNA Tests). Its focus is on developing and providing Genetic Testing Analysis both in Medical and Direct-To-Consumer Genomics sectors, with research activity through cooperation with universities in Greece and abroad.